IN2012DE00826A - - Google Patents

Download PDF

Info

Publication number
IN2012DE00826A
IN2012DE00826A IN826DE2012A IN2012DE00826A IN 2012DE00826 A IN2012DE00826 A IN 2012DE00826A IN 826DE2012 A IN826DE2012 A IN 826DE2012A IN 2012DE00826 A IN2012DE00826 A IN 2012DE00826A
Authority
IN
India
Prior art keywords
composition
relates
release form
phentennine
topiramate
Prior art date
Application number
Inventor
Kumar Fanda Anuj
Vivek Kumaravel
Sharma Ravish
Barat Singh Romi
Kumar Singla Ajay
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN826DE2012 priority Critical patent/IN2012DE00826A/en
Priority to US13/848,476 priority patent/US20130251793A1/en
Publication of IN2012DE00826A publication Critical patent/IN2012DE00826A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Abstract

This invention relates to a pharmaceutical composition comprising a combination of phentennine in an immediate release form and topiramate in an extended release form. Further, it relates to processes for the preparation of the composition and the method of using the composition.
IN826DE2012 2012-03-21 2012-03-21 IN2012DE00826A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN826DE2012 IN2012DE00826A (en) 2012-03-21 2012-03-21
US13/848,476 US20130251793A1 (en) 2012-03-21 2013-03-21 Pharmaceutical composition comprising phentermine and topiramate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN826DE2012 IN2012DE00826A (en) 2012-03-21 2012-03-21

Publications (1)

Publication Number Publication Date
IN2012DE00826A true IN2012DE00826A (en) 2015-08-21

Family

ID=49212034

Family Applications (1)

Application Number Title Priority Date Filing Date
IN826DE2012 IN2012DE00826A (en) 2012-03-21 2012-03-21

Country Status (2)

Country Link
US (1) US20130251793A1 (en)
IN (1) IN2012DE00826A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3142644A1 (en) * 2014-05-16 2017-03-22 Vivus, Inc. Orally administrable formulations for the controlled release of a pharmacologically active agent
ES2885437T3 (en) * 2015-03-03 2021-12-13 Saniona As Combination formulation of tesofensin and metoprolol
PE20231051A1 (en) * 2020-07-27 2023-07-11 Eurofarma Laboratorios S A CRYSTALLINE FORM OF PHENTERMINE HYDROCHLORIDE AND PROCESS FOR OBTAINING IT

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1845953A1 (en) * 2005-02-03 2007-10-24 Pfizer Products Incorporated Dosage forms providing controlled and immediate release of cholesteryl ester transfer protein inhibitors and immediate release of hmg-coa reductase inhibitors
US20080145127A1 (en) * 2006-10-10 2008-06-19 Hang Yu Liu Book-shaped, back-typing, ergonomic computer keyboard
US20090304789A1 (en) * 2008-06-09 2009-12-10 Thomas Najarian Novel topiramate compositions and an escalating dosing strategy for treating obesity and related disorders

Also Published As

Publication number Publication date
US20130251793A1 (en) 2013-09-26

Similar Documents

Publication Publication Date Title
IL285390A (en) Arylquinazolines, their preparation and pharmaceutical compositions containing them
EP2927227A4 (en) Antibody-linker-drug conjugate, preparation method therefor, and anticancer drug composition containing same
HK1200727A1 (en) Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same
IL236268B (en) Compositions for transmucosal delivery and uses thereof
ZA201404625B (en) Polycyclic derivatives, preparation method and medical uses thereof
MX2021004211A (en) Vaccine compositions.
HK1206045A1 (en) Compositions containing n-acetylcaprolactam, their preparation and their use for producing cast polyamides n-
EP2829267A4 (en) Topiramate sustained-release pharmaceutical composition, method for preparing same, and use thereof
HK1203815A1 (en) Pharmaceutical compositions and methods for their preparation
MX2014010433A (en) Novel crystalline form of sitagliptin sulfate.
MX2013013649A (en) Quinone compounds for treating ape1 mediated diseases.
EP2931310A4 (en) Compositions, methods of administration and uses for trivalent dengue virus formulations
EP2924042A4 (en) Bis- -carboline compound and preparation method, pharmaceutical composition and use thereof
HK1222336A1 (en) Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation
EP3078659A4 (en) 3-furyl-2-cyano-2-acrylamide derivative, preparation method therefor, pharmaceutical composition and use thereof
IN2012DE00826A (en)
ZA201306419B (en) Compositions and methods for separating,characterizing and administering soluble selenoglycoproteins
EP2704570A4 (en) Drug substances, pharmeceutical compositions and methods for preparing the same
IL236562A0 (en) Pharmaceutical composition having improved flowability, medicinal agent, and method for producing and using same
EP2862937A4 (en) Method for producing phospholipid-containing composition, and phospholipid-containing composition
MX2015005510A (en) Solid salt form of alpha-6-mpeg6-o-hydroxycodone as opioid agonists and uses thereof.
MX2014004210A (en) 2-oxo-piperidinyl derivatives.
IN2013MU03317A (en)
IL234614B (en) Pharmaceutical composition and preparation method thereof
MX2012014969A (en) Stable pharmaceutical compositions comprising amlodipine and telemisartan.